Bristol Myers Squibb Cancer Immunotherapy Flunks a Key Test in Melanoma

Bristol Myers Squibb’s Opdualag paired with blockbuster immunotherapy Opdivo failed a clinical trial testing the regimen as an adjuvant therapy for patients whose melanoma has been surgically removed. While Opdualag is still projected to reach blockbuster status, it could face competition from a Regeneron Pharmaceuticals drug. The post Bristol Myers Squibb Cancer Immunotherapy Flunks a…

Read More

Women’s History Month Spotlight: Maureen Gremminger

Maureen Gremminger, EVS Resident Regional Manager, Inspira Health Network in Mullica Hill, New Jersey I was an office manager at a moving company before joining Crothall’s Manager in Training program in 2012. At that time, I met Joce-Lyn Hanton, who was an operations manager.  She was so inspirational; she knew everything about cleaning.  The first…

Read More